Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program

NCT06411951 | Enrolling By Invitation DMC

• 1 other identifier: 2023-00836
• Study Type: observational
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

The study aims to evaluate the treatment effects as well as inhibiting and promoting factors in the implementation of the new INTUK care offer in a sample of "heavy users", i.e. psychiatric patients with 4 or more prior inpatient admissions at Klinik Zugersee, by means of a longitudinal, prospective-retrospective study. For this purpose, medical records will be analysed and participants will be asked to fill out questionnaires addressing different aspects of mental health, quality of life and patient satisfaction. In addition, semi-structured interviews will be conducted with a subset of patients as well as staff members of the INTUK care offer.

Conditions

High Utilization / Heavy Use; Psychiatric Hospitalization; Rehospitalization; Intensive Care Psychiatric Disorder; Chronic Psychiatric Disorder; Health Care Utilization

Outcome Measures

Primary Outcomes (1)

• Admission rate

  Participation in the INTUK program will be associated with a significant change in the total number of inpatient admissions.

  01.06.2023 - 31.05.2027

Secondary Outcomes (4)

• Length of hospital stays

  01.06.2023 - 31.05.2027

• Treatment effects

  01.06.2023 - 31.05.2027

• Treatment effects

  01.06.2023 - 31.05.2027

• Treatment effects

  01.06.2023 - 31.05.2027

Interventions

Participation in the INTUK care offer at Klinik Zugersee OTHER

Person-centered treatment and care tailored to the individual patients needs by a team consisting of a senior physician, a nurse, social workers and peers.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Psychiatric patients with 4 or more inpatient admissions at Klinik Zugersee in the past 24 months.

You may qualify if:

• Psychiatric patients with 4 or more inpatient admissions at Klinik Zugersee in the past 24 months.

You may not qualify if:

• Age \< 18 years.
• Lack of written informed consent.
• Incapability of judgement.

Sponsors & Collaborators

• Michael Rufer: lead
• University of Zurich: collaborator

Study Sites (1)

Triaplus AG - Klinik Zugersee

Oberwil, Canton of Zug, 6317, Switzerland

Location

MeSH Terms

Conditions

Patient Acceptance of Health Care

Condition Hierarchy (Ancestors)

Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Michael Rufer, Prof. Dr.

  Triaplus AG - Klinik Zugersee

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Prof. Dr. med. Michael Rufer

Study Record Dates

• First Submitted: April 30, 2024
• First Posted: May 14, 2024
• Study Start: June 1, 2023
• Primary Completion (Estimated): May 31, 2027
• Study Completion (Estimated): December 31, 2027
• Last Updated: May 16, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

CH (1)